BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 16844713)

  • 1. Network modulation in the treatment of Parkinson's disease.
    Asanuma K; Tang C; Ma Y; Dhawan V; Mattis P; Edwards C; Kaplitt MG; Feigin A; Eidelberg D
    Brain; 2006 Oct; 129(Pt 10):2667-78. PubMed ID: 16844713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease.
    Trost M; Su S; Su P; Yen RF; Tseng HM; Barnes A; Ma Y; Eidelberg D
    Neuroimage; 2006 May; 31(1):301-7. PubMed ID: 16466936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in network activity with the progression of Parkinson's disease.
    Huang C; Tang C; Feigin A; Lesser M; Ma Y; Pourfar M; Dhawan V; Eidelberg D
    Brain; 2007 Jul; 130(Pt 7):1834-46. PubMed ID: 17470495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study.
    Nimura T; Yamaguchi K; Ando T; Shibuya S; Oikawa T; Nakagawa A; Shirane R; Itoh M; Tominaga T
    J Neurosurg; 2005 Dec; 103(6):968-73. PubMed ID: 16381182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of metabolic brain function by bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease.
    Wang J; Ma Y; Huang Z; Sun B; Guan Y; Zuo C
    J Neurol; 2010 Jan; 257(1):72-8. PubMed ID: 19662326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic correlates of subthalamic nucleus activity in Parkinson's disease.
    Lin TP; Carbon M; Tang C; Mogilner AY; Sterio D; Beric A; Dhawan V; Eidelberg D
    Brain; 2008 May; 131(Pt 5):1373-80. PubMed ID: 18400841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified Fluorodeoxyglucose Metabolism in Motor Circuitry by Subthalamic Deep Brain Stimulation.
    Cao C; Zhang H; Li D; Zhan S; Zhang J; Zhang X; Zuo C; Sun B
    Stereotact Funct Neurosurg; 2017; 95(2):93-101. PubMed ID: 28259880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility.
    Ma Y; Tang C; Spetsieris PG; Dhawan V; Eidelberg D
    J Cereb Blood Flow Metab; 2007 Mar; 27(3):597-605. PubMed ID: 16804550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease.
    Stefani A; Lozano AM; Peppe A; Stanzione P; Galati S; Tropepi D; Pierantozzi M; Brusa L; Scarnati E; Mazzone P
    Brain; 2007 Jun; 130(Pt 6):1596-607. PubMed ID: 17251240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease.
    Devos D; Labyt E; Derambure P; Bourriez JL; Cassim F; Reyns N; Blond S; Guieu JD; Destée A; Defebvre L
    Brain; 2004 Feb; 127(Pt 2):408-19. PubMed ID: 14691060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep brain stimulation of the subthalamic nucleus versus levodopa challenge in Parkinson's disease: measuring the on- and off-conditions with FDG-PET.
    Hilker R; Voges J; Thiel A; Ghaemi M; Herholz K; Sturm V; Heiss WD
    J Neural Transm (Vienna); 2002 Oct; 109(10):1257-64. PubMed ID: 12373559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial.
    Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM
    Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microlesion effect as a predictor of the effectiveness of subthalamic deep brain stimulation for Parkinson's disease.
    Tykocki T; Nauman P; Koziara H; Mandat T
    Stereotact Funct Neurosurg; 2013; 91(1):12-7. PubMed ID: 23154788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease.
    Hilker R; Voges J; Weisenbach S; Kalbe E; Burghaus L; Ghaemi M; Lehrke R; Koulousakis A; Herholz K; Sturm V; Heiss WD
    J Cereb Blood Flow Metab; 2004 Jan; 24(1):7-16. PubMed ID: 14688612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of secondary unresponsiveness to dopaminergic drugs with preserved response to subthalamic nucleus stimulation in Parkinson's disease.
    Lenka A; Jhunjhunwala KR; Stezin A; Manjunath M; Srinivas D; Yadav R; Pal PK
    Neurol India; 2018; 66(Supplement):S135-S137. PubMed ID: 29503336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pallidal deep brain stimulation and L-dopa effect on PET motor activation in advanced Parkinson's disease.
    Valálik I; Emri M; Lengyel Z; Mikecz P; Trón L; Csókay A; Márián T
    J Neuroimaging; 2009 Jul; 19(3):253-8. PubMed ID: 19021848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial.
    Witt K; Granert O; Daniels C; Volkmann J; Falk D; van Eimeren T; Deuschl G
    Brain; 2013 Jul; 136(Pt 7):2109-19. PubMed ID: 23801735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.